Yutiq (fluocinolone acetonide intravitreal implant) / EyePoint Pharma |
NCT05322070: Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis |
|
|
| Active, not recruiting | 4 | 125 | US | Fluocinolone Acetonide Intravitreal Implant 0.18 mg, YUTIQ 0.18 mg | Alimera Sciences, CBCC Global Research | Uveitis, Posterior | 11/25 | 11/25 | | |
NCT05070728: Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert (FAI) |
|
|
| Terminated | 3 | 12 | US | Sham Injector, Sham Comparator, FAI Insert, Active Drug | EyePoint Pharmaceuticals, Inc. | Uveitis, Uveitis, Posterior, Uveitis, Intermediate | 10/22 | 04/23 | | |
TYNI, NCT05486468: The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment |
|
|
| Recruiting | 3 | 30 | US | Yutiq 0.18 MG Drug Implant, Sham Injection | Texas Retina Associates, Eye Point Pharmaceuticals | Uveitis, Uveitis, Posterior, Uveitis, Anterior, Uveitis, Intermediate | 12/23 | 12/24 | | |
NCT04918121: A Study of Yutiq Steroid Insert During Glaucoma Tube Implant Surgery |
|
|
| Recruiting | 1 | 5 | US | Yutiq 0.18 MG Drug Implant | Sanjay Asrani | Glaucoma | 12/24 | 12/24 | | |
NCT05592717: A Study of YUTIQ® 0.18 mg Intravitreal Implant for the Management of Chronic Non-infectious Uveitis |
|
|
| Recruiting | N/A | 15 | RoW | Yutiq | Tianjin Medical University | Uveitis, YUTIQ | 11/25 | 11/26 | | |